Yanbing Q. Ma
2 Cuihu North Road
Kunming, 650091, China
Kunming, 650091, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Evaluation of Centella asiatica Germplasm Resources in Yunnan, China, Based on Phenotypic Traits, SSR Markers, and Chemical Profiling.
Journal: Plants (Basel, Switzerland)
Published: May 27, 2026
Tumor Vaccine Exploiting Membranes with Influenza Virus-Induced Immunogenic Cell Death to Decorate Polylactic Coglycolic Acid Nanoparticles.
Journal: ACS nano
Published: January 14, 2025
Genetically modified bacterial vesicles with interferon-γ and tumor antigen remodel anti-tumor cellular immunity by modulating dendritic cells.
Journal: Biomaterials
Published: December 03, 2024
Tumor microenvironment remodeling with a telomere-targeting agent and its cooperative antitumor effects with a nanovaccine.
Journal: Journal of nanobiotechnology
Published: November 07, 2024
A personalized vaccine combining immunogenic cell death-induced cells and nanosized antigens for enhanced antitumor immunity.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: July 04, 2024
Engineered Bacterial Biomimetic Vesicles Reprogram Tumor-Associated Macrophages and Remodel Tumor Microenvironment to Promote Innate and Adaptive Antitumor Immune Responses.
Journal: ACS nano
Published: February 22, 2024
Peptide-Based Therapeutic HPV Cancer Vaccine Synthesized via Bacterial Outer Membrane Vesicles.
Journal: International journal of nanomedicine
Published: May 05, 2023
Exploiting immunostimulatory mechanisms of immunogenic cell death to develop membrane-encapsulated nanoparticles as a potent tumor vaccine.
Journal: Journal of nanobiotechnology
Published: April 25, 2023
Neoantigen-Based Nanovaccine In Combination with Immune Checkpoint Inhibitors Abolish Postsurgical Tumor Recurrence and Metastasis.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: April 07, 2023
Engineered Norovirus-Derived Nanoparticles as a Plug-and-Play Cancer Vaccine Platform.
Journal: ACS nano
Published: February 13, 2023
A "trained immunity" inducer-adjuvanted nanovaccine reverses the growth of established tumors in mice.
Journal: Journal of nanobiotechnology
Published: January 19, 2023
Last Updated: 09/26/2026